Acknowledgements Learning objectives Privacy Policy Cookie Policy How Can We Help?

ObesityWeek® 2023

Medfyle Conference Coverage
Privacy Policy.



THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM LILLY

Welcome

ObesityWeek® took place in Dallas, Texas from October 14-17, 2023. ObesityWeek® Medfyle Conference Coverage features curated bite-size summaries of key oral and poster sessions as well as expert video interviews to help busy clinicians stay on top of the latest advancements in the field of obesity research and care.

Interviews

Gain valuable insights from an international panel of experts.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
See all

ObesityWeek 2023 summaries Summaries

Missed the full presentation? Read at-a-glance summaries from a selection of oral presentations. Don’t forget to download the slides!
See all
Treatments & Lifestyle

SURMOUNT-3: tirzepatide treatment for obesity following intensive lifestyle intervention

Sriram Machineni, MD; Ariana M. Chao, PhD, CRNP; Ania M. Jastreboff, MD, PhD; Jamy D. Ard, MD

Tirzepatide substantially increased the magnitude of weight loss when administered after an initial intensive lifestyle intervention lasting 12 weeks.

ObesityWeek 2023 - Oral presentation

SURMOUNT-3

Read more

01-surmount-3-tirzepatide-treatment-for-obesity-following-intensive-lifestyle-intervention
Treatments

Weight loss maintenance in older adults with obesity

Mohammad I. Bhatti, Medical student

Long-term weight loss maintenance and tolerability to antiobesity medications were comparable in patients ≥65 years and those <65 years.

ObesityWeek 2023 - Oral presentation

Long-term Weight Loss Maintenance in Older Adults Treated with Obesity Pharmacotherapy

Read more

02-weight-loss-maintenance-in-older-adults-with-obesity

ObesityWeek 2023 summaries Posters

Read at-a-glance summaries from a selection of poster presentations.
See all
Treatments

Assessing long-term clinical outcomes and lifestyle modifications with tirzepatide in patients affected by obesity

Meredith Hoog, MPH

Based on the positive results of SURMOUNT-1 trial, this study estimated long-term clinical outcomes in patients with overweight/obesity treated with tirzepatide. A decreased incidence in complications related to obesity such as T2D was found compared to lifestyle modifications.

ObesityWeek 2023 - Poster presentation

Modelling Outcomes of Tirzepatide Versus Lifestyle Modification for Overweight and Obesity

Read more

01-p-assessing-long-term-clinical-outcomes-and-lifestyle-modifications-with-tirzepatide-in-patients-affected-by-obesity
Bariatric surgery

Association between pre-surgical factors and cardiometabolic parameters in bariatric surgery

Lei Wang, MPhil, PhD student

In this large multi-racial, longitudinal study, demographic factors and clinical condition predicted more significant improvement in cardiometabolic parameters after bariatric surgery.

ObesityWeek 2023 - Poster presentation

Cardiometabolic Improvements After Bariatric Surgery and Associated Pre-surgery Factors

Read more

03-p-association-between-pre-surgical-factors-and-cardiometabolic-parameters-in-bariatric-surgery

Deep Dives

Watch on-demand videos, led by experts, to dive deeper into subjects of special interest.

See all
Feedback My Library

Purchase access to all ObesityWeek® Session Recordings OnDemand
Missed ObesityWeek®? You can now watch all scientific sessions OnDemand.
Available through December 31, 2023.

More Info

Join The Obesity Society mailing list

to learn about future ObesityWeeks
Subscribe

Ask the Expert

Have a question? Submit it below.
A selection of the most interesting questions will be answered in a new video. You will receive an email when answers will be published.